Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-Stage Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00494026
What this trial is testing

Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 4
Early research (Phase 1)Study completedNCT00019006
What this trial is testing

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

Who this might be right for
Recurrent Colon CancerExtensive Stage Small Cell Lung CancerStage III Pancreatic Cancer+11 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Testing effectiveness (Phase 2)Active Not RecruitingNCT03540420
What this trial is testing

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Norwegian University of Science and Technology 212
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07167459
What this trial is testing

Personalized SBRT in Early-Stage Peripheral NSCLC

Who this might be right for
Early-stage Peripheral Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 251
Early research (Phase 1)Study completedNCT00068549
What this trial is testing

Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+6 more
Gynecologic Oncology Group 13
Testing effectiveness (Phase 2)Study completedNCT00003379
What this trial is testing

Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 40
Testing effectiveness (Phase 2)Ended earlyNCT00087269
What this trial is testing

Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection

Who this might be right for
Stage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 110
Not applicableLooking for participantsNCT06737107
What this trial is testing

Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer

Who this might be right for
Early Stage Lung Cancer (I and II)Non-Small Cell Lung Cancer
Scientific Institute San Raffaele 472
Not applicableNot Yet RecruitingNCT07327736
What this trial is testing

Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT

Who this might be right for
Patients With Suspected Non-small Cell Lung Cancer (NSCLC) at Clinical Stage T1
Tang-Du Hospital 410
Not applicableLooking for participantsNCT07257471
What this trial is testing

Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy

Who this might be right for
Lung Cancer (NSCLC)
Beijing Haidian Hospital 30
Not applicableLooking for participantsNCT04944563
What this trial is testing

Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field

Who this might be right for
Lung NeoplasmsSurgery
The First Affiliated Hospital with Nanjing Medical University 1,120
Large-scale testing (Phase 3)Active Not RecruitingNCT07128199
What this trial is testing

Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

Who this might be right for
Lung CancerAdjuvantPost-surgical+5 more
Taiho Oncology, Inc. 360
Early research (Phase 1)Looking for participantsNCT06566443
What this trial is testing

Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
The Methodist Hospital Research Institute 15
Not applicableUnknownNCT01450553
What this trial is testing

Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease

Who this might be right for
Non-Small Cell Lung Cancer
Precision Therapeutics 450
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06784206
What this trial is testing

Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer, Limited StageHyperfractionated Accelerated RadiotherapySimultaneous Radiotherapy and Chemotherapy
Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)Study completedNCT00193375
What this trial is testing

Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 60
Testing effectiveness (Phase 2)UnknownNCT03585998
What this trial is testing

Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Samsung Medical Center 51
Not applicableUnknownNCT06483919
What this trial is testing

The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Jinming Yu 228
Testing effectiveness (Phase 2)UnknownNCT03613597
What this trial is testing

Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Guizhou Medical University 118
Next Page